08:00 , Nov 12, 2012 |  BC Week In Review  |  Company News

Boston Oncology LLC, Oncobiologics deal

Boston Oncology received rights in the Middle East and North African regions to develop and commercialize four undisclosed biosimilars to treat cancer and immunological diseases from Oncobiologics. Oncobiologics will receive upfront payments and is eligible...